JPMorgan Chase & Co. Acquires 225,238 Shares of Varex Imaging $VREX
JPMorgan Chase & Co. significantly increased its stake in Varex Imaging (NASDAQ:VREX) by 381.8% in the third quarter, acquiring an additional 225,238 shares to own a total of 284,227 shares valued at approximately $3.52 million. This move makes JPMorgan Chase & Co. a 0.68% shareholder in the company. The article also notes mixed analyst ratings for Varex, with a consensus "Hold" rating and a $16.17 average target price, following the company's Q1 earnings beat and Q2 2026 guidance.
VREX Stock News Today | Earnings, Events & Price Alerts
This article provides recent news and event updates for Varex Imaging (VREX), including a new credit agreement, investor conference presentations, and senior secured notes redemption. Key financial announcements detail Q1 2026 revenue exceeding expectations at $210 million, driven by strength in cargo systems, and a Q2 revenue outlook of $210M to $225M. Analyst predictions also suggest a potential 29.92% rise for VREX.
VREX Technical Analysis & Stock Price Forecast
This article provides a technical analysis and stock price forecast for Varex Imaging Corp (VREX), indicating a "Strong Sell" consensus based on various technical indicators. The analysis covers moving averages, momentum indicators like RSI and MACD, and identifies key support and resistance levels. The stock is currently trading below its 200-day moving average, reinforcing the bearish sentiment.
Trading the Move, Not the Narrative: (VREX) Edition
This article provides an AI-generated analysis for Varex Imaging Corporation (NASDAQ: VREX), highlighting divergent sentiment across different time horizons and suggesting choppy conditions. It presents three distinct trading strategies (Position, Momentum Breakout, Risk Hedging) tailored to various risk profiles, along with multi-timeframe signal analysis indicating support and resistance levels. The report emphasizes trading the move rather than the narrative, leveraging institutional-grade predictive AI.
VREX SEC Filings - Varex Imaging Corp 10-K, 10-Q, 8-K Forms
This page provides a comprehensive overview of Varex Imaging Corp (VREX) SEC filings, including 10-K annual reports, 10-Q quarterly reports, and 8-K material event forms. It details recent filings such as a 10-Q quarterly earnings report, Pzena Investment's increased ownership to over 10%, and a director's stock sale. The platform offers AI-powered summaries to help investors quickly grasp key information from these regulatory documents.
Varex Imaging (VREX) SVP Jesse Merkley reports shares, RSUs, PSUs and options
Varex Imaging Corp's SVP and GM, Industrial, Jesse Don Merkley, filed an initial ownership report detailing his equity holdings in the company. The report indicates he directly holds 15,334 shares of common stock, alongside various equity awards including restricted stock units (RSUs), performance stock units (PSUs), and a non-qualified stock option for 9,727 shares. These awards are subject to vesting schedules and performance conditions, demonstrating a comprehensive equity compensation structure for the executive.
Varex Imaging Corp (NASDAQ: VREX) — Vanguard files amendment showing 0% ownership
The Vanguard Group filed an amended Schedule 13G/A for Varex Imaging Corp (VREX), reporting 0 shares beneficially owned, representing 0% of the class. This amendment follows an internal realignment at Vanguard effective January 12, 2026, which prompted subsidiaries to report their holdings separately. The filing confirms that The Vanguard Group itself no longer retains beneficial ownership over these securities, with future filings expected from disaggregated entities.
Varex Imaging (VREX) SVP Garcia details stock, RSU and option holdings
Varex Imaging Corp's Senior Vice President of Regulatory and Quality Assurance, Victor Hugo Garcia, filed a Form 3 detailing his equity holdings in the company. The filing indicates direct ownership of 23,360 shares of common stock, in addition to various restricted stock units, performance stock units, and non-qualified stock options. These holdings represent Garcia's existing stake and not new open-market transactions.
Varex Imaging (VREX) director sells 4,510 shares, keeps 23,450
Varex Imaging Corp director Jay K. Kunkel sold 4,510 shares of common stock at $11.14 per share in an open-market transaction on March 20, 2026. Following this sale, Kunkel directly holds 23,450 shares, maintaining a significant equity stake in the company. The transaction was filed as a Form 4 with the SEC.
Varex Imaging Says Demand Steady Despite Geopolitics; Tariff Relief to Lift Margins, India Ramp Ahead
Varex Imaging (NASDAQ:VREX) reports steady demand despite geopolitical events, with healthcare and industrial markets remaining stable, and security-related inquiries increasing. The company anticipates modest gross margin improvements from tariff relief and is pursuing supply chain diversification. Key growth drivers include manufacturing expansion in India, development of photon-counting CT detectors, and growth in cargo inspection systems, alongside interest savings from a recent debt refinancing.
Varex Imaging Says Demand Steady Despite Geopolitics; Tariff Relief to Lift Margins, India Ramp Ahead
Varex Imaging reported stable demand despite geopolitical events and tariff volatility, noting healthcare and non-destructive testing are largely unaffected, while security-related inquiries are rising. The company anticipates modest gross margin improvements as higher-tariff inventory clears, and expects significant growth from India manufacturing expansion, photon-counting CT detectors, cargo inspection systems, and recent debt refinancing. These initiatives are projected to boost revenue, profitability, and annual EPS.
VREX (NASDAQ: VREX) files Rule 144 notice listing 4,510 vested shares
Varex Imaging Corp (NASDAQ: VREX) has filed a Rule 144 notice for the proposed sale of 4,510 vested common shares through Fidelity Brokerage Services LLC. The filing details two tranches of restricted stock vesting: 875 shares on February 13, 2023, and 3,635 shares on February 11, 2024. This administrative disclosure does not specify sale timing or methods but provides information on the shares for sale the broker, and the market (NASDAQ).
Form 144 Varex Imaging Corp For: 20 March
This article announces the filing of Form 144 by Varex Imaging Corp for March 20. It includes standard disclaimers about the risks associated with trading financial instruments and cryptocurrencies, emphasizing that the provided data may not be real-time or accurate. The content advises potential investors to seek professional advice and be aware of the high risks involved in trading.
Form 144 Varex Imaging Corp For: 20 March
This article announces the filing of Form 144 for Varex Imaging Corp on March 20. It provides this information without further detail, likely serving as a routine financial market update. The page also includes broader market data and other news headlines.
VREX SEC Filings - Varex Imaging Corp 10-K, 10-Q, 8-K Forms
This page provides a comprehensive resource for Varex Imaging Corp (VREX) SEC filings, including annual 10-K, quarterly 10-Q, and material 8-K reports, as well as insider trading forms. It details Varex's business in X-ray imaging components and systems, offering insights into financial performance, risk factors, and governance. The platform also features AI-powered summaries of these documents and tracks insider activity.
Varex Imaging Refinances Debt With New Credit Facility
Varex Imaging has refinanced its debt by entering into a new $490 million secured credit facility maturing in 2031, which allowed it to redeem its existing 7.875% Senior Secured Notes due 2027. This move is expected to reduce annual cash interest expense by over $7 million and enhance financial flexibility. Despite strong revenue growth, Spark, TipRanks' AI Analyst, rates VREX as Neutral due to weakened financial performance.
Varex Imaging: $490 Million Credit Facility Refinancing To Strengthen Balance Sheet And Lower Interest Costs
Varex Imaging has completed a $490 million debt refinancing, consisting of a $350 million term loan, a $100 million revolving facility, and a $40 million delayed draw term loan, all maturing in March 2031. This refinancing allowed the company to redeem its high-interest notes and is projected to reduce annual cash interest expenses by over $7 million. The move is expected to improve financial flexibility, enhance free cash flow, and support continued investment in its core business.
Varex’s new $490M loan deal aims to save over $7M a year in interest
Varex Imaging Corporation has completed a debt refinancing by entering a new Credit and Guaranty Agreement for $490 million, replacing its previous credit facility and redeeming existing Senior Secured Notes. This move is expected to reduce the company's annualized cash interest expense by over $7 million, improve financial flexibility, and support free cash flow generation. The new credit facility includes a secured term loan, a revolving credit facility, and a delayed draw term loan.
Varex Imaging Announces $490 Million Debt Refinancing to Reduce Interest Expense and Strengthen Balance Sheet
Varex Imaging Corporation has completed a $490 million debt refinancing, entering into a new Credit Facility to replace its previous arrangements. This move includes a $350 million secured term loan, a $100 million revolving credit facility, and a $40 million delayed draw term loan, all maturing in March 2031. The refinancing is expected to reduce annualized cash interest expense by over $7 million and strengthen the company's balance sheet, improving financial flexibility and free cash flow generation.
VREX SEC Filings - Varex Imaging Corp 10-K, 10-Q, 8-K Forms
This page provides a comprehensive resource for Varex Imaging Corporation (VREX) SEC filings, including annual reports (10-K), quarterly reports (10-Q), material event reports (8-K), and insider trading forms. It highlights recent insider trading activities with detailed summaries from Form 4 filings, showing conversions of deferred stock units into common shares by various directors and performance stock unit updates for executives. The article explains how the platform offers AI-powered summaries to help investors quickly understand key financial and governance disclosures.
Varex Imaging Secures $490 Million Credit Facilities to Refinance 2027 Notes
Varex Imaging has secured new credit facilities totaling $490 million, including a $350 million term loan, $100 million revolver, and $40 million delayed draw term loan. The company used $350 million from this agreement to fully redeem its 7.875% Senior Secured Notes due 2027 and terminated its previous $155 million revolving credit agreement. These actions aim to streamline Varex's capital structure, reduce debt costs, and enhance liquidity.
Varex Imaging (Nasdaq: VREX) trims debt and locks in $490M credit to 2031
Varex Imaging Corporation has refinanced its debt by securing a new $490 million Credit and Guaranty Agreement, comprising a $350 million secured term loan, a $100 million secured revolving credit facility, and a $40 million secured delayed draw term loan, all maturing in March 2031. This refinancing allowed the company to redeem its $368 million 7.875% Senior Secured Notes due 2027, reducing outstanding debt by $18 million and is expected to save over $7 million in annual cash interest expense. The new credit facility includes SOFR-based variable interest, with an interest rate swap fixing the SOFR component at 3.65% to provide more predictable funding costs.
Varex Announces Successful Completion of Debt Refinancing
Varex Imaging Corporation announced the successful completion of a debt refinancing, entering into a new Credit and Guaranty Agreement totaling $490 million. This new facility allowed the company to redeem its outstanding $368 million 7.875% Senior Secured Notes due 2027 and terminate its previous revolving credit facility. The refinancing is expected to strengthen Varex's balance sheet, reduce interest expenses by over $7 million annually, and improve financial flexibility.
Price-Driven Insight from (VREX) for Rule-Based Strategy
Quantitative Research Desk provides an AI-driven analysis for Varex Imaging Corporation (NASDAQ: VREX), highlighting weak near and mid-term sentiment but a strong long-term outlook. The report offers three trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels. It also details multi-timeframe signal analysis indicating support and resistance levels for different time horizons.
Varex Management to Present in Upcoming Investor Conferences
Varex Imaging Corporation announced that its management is scheduled to present at two upcoming investor conferences: Oppenheimer’s 36th Annual Healthcare, MedTech & Services Virtual Conference on Tuesday, March 17, 2025, and the Sidoti Small Cap Virtual Conference on Wednesday, March 18, 2026. Webcast links for both presentations are available on Varex's website. Varex is a leading designer and manufacturer of X-ray imaging components used in medical, industrial, and security applications.
Varex Management to Present in Upcoming Investor Conferences
Varex Imaging Corporation announced that its management is scheduled to present at two upcoming investor conferences: Oppenheimer’s 36th Annual Healthcare, MedTech & Services Virtual Conference on March 17, 2025, and the Sidoti Small Cap Virtual Conference on March 18, 2026. Webcast links for both presentations are available on Varex’s website. The company specializes in X-ray imaging components for medical, industrial, and security applications.
Varex investor webcasts set for Oppenheimer and Sidoti conferences
Varex Imaging Corporation (Nasdaq: VREX) announced that its management is scheduled to present at two upcoming virtual investor conferences: Oppenheimer’s 36th Annual Healthcare, MedTech & Services Conference on March 17, 2025, and the Sidoti Small Cap Virtual Conference on March 18, 2026. Webcasts for both events will be accessible via Varex's website. Varex is a leading designer and manufacturer of X-ray imaging components for medical, industrial, and security applications.
VREX Earnings History & Surprises | EPS & Revenue Results | VAREX IMAGING CORP (NASDAQ:VREX)
This article provides a comprehensive overview of VAREX IMAGING CORP (VREX) earnings history, including past quarterly EPS and revenue results, analyst estimates, and surprise percentages. It details upcoming earnings dates and offers an analysis of beat rates over the last four quarters, highlighting consistent EPS beats and frequent revenue beats. The report also includes graphical representations of EPS and revenue quarter-over-quarter growth trends.
Varex Imaging Corporation to redeem its 7.875% senior secured notes due 2027
Varex Imaging Corporation announced its intention to redeem its 7.875% senior secured notes due 2027. The company's stock, VREX, closed at 11.40 USD with a recent decrease. Analysts currently have an average target price of 18.40 USD for Varex Imaging.
Varex Imaging Corporation to Redeem Its 7.875% Senior Secured Notes Due 2027
Varex Imaging Corporation announced its conditional full redemption of all outstanding 7.875% senior secured notes due October 15, 2027, totaling $368 million, on March 16, 2026. The redemption is conditional upon securing new financing to fund the payment of $1,052.72125 per $1,000 principal amount. If the financing condition is not met, the redemption may be delayed or terminated.
Varex Imaging Corporation to Redeem Its 7.875% Senior Secured Notes Due 2027
Varex Imaging Corporation announced its conditional full redemption of all outstanding 7.875% senior secured notes due October 15, 2027, on March 16, 2026. The redemption is contingent upon the funding of a new credit facility and cash on hand. The company, a leading innovator in X-ray imaging components, emphasizes that this press release is for informational purposes only and does not constitute a notice of redemption or an offer to sell securities.
Varex Imaging Corp. Experiences Revision in Stock Evaluation Amid Mixed Market Signals
Varex Imaging Corp. has revised its stock evaluation, currently priced at $12.58, showing mixed technical indicators despite some positive momentum. The company, a microcap player in Pharmaceuticals & Biotechnology, has faced market challenges, underperforming the S&P 500 over several periods, particularly in the long term. This highlights its ongoing struggles within a competitive market.
VREX Financials: Income Statement, Balance Sheet & Cash Flow
This article provides an in-depth financial analysis of Varex Imaging Corp (VREX), detailing its income statement, balance sheet, and cash flow statement for annual and quarterly periods. It also evaluates key financial health indicators such as profitability, growth, leverage, liquidity, and cash flow, along with an F-Score and earnings quality assessment. The report highlights that VREX generated $844.6M in revenue in FY2025 but reported a net income loss of -$70.3M and has an "at risk" interest coverage ratio.
Varex Imaging (NASDAQ:VREX) Upgraded at Wall Street Zen
Wall Street Zen has upgraded Varex Imaging (NASDAQ:VREX) from a "buy" to a "strong-buy" rating. This upgrade is part of a mixed analyst sentiment, resulting in a consensus "Hold" rating and a target price of $16.17 for the company. Varex Imaging recently exceeded quarterly earnings and revenue expectations and has provided Q2 2026 guidance.
Director at Varex Imaging (VREX) awarded 14,947 deferred stock units
Walter M. Rosebrough Jr., a director at Varex Imaging (VREX), was granted 14,947 Deferred Stock Units on February 12, 2026. These units, awarded as equity compensation at a price of $0, will convert into Varex Imaging common stock on a one-for-one basis. The units vest 100% on the earlier of one year from the grant date or the next annual stockholders' meeting, with the underlying shares delivered upon the earlier of the third anniversary of the grant, a change in control, or the director's termination of service.
(VREX) as a Liquidity Pulse for Institutional Tactics
This article provides an institutional tactical analysis for Varex Imaging Corporation (NASDAQ: VREX), highlighting weak near and mid-term sentiment but a strong long-term outlook. It details AI-generated trading strategies including position, momentum breakout, and risk hedging, alongside multi-timeframe signal analysis and risk-reward setups. The analysis offers specific entry, target, and stop-loss levels for different trading approaches.
Director Bardwell granted 12,331 deferred stock units at Varex (VREX)
Varex Imaging Corp director Kathleen Bardwell was granted 12,331 Deferred Stock Units (DSUs) on February 12, 2026, as reported in an SEC Form 4 filing. These DSUs convert to common stock on a one-for-one basis and vest 100% on the earlier of the one-year anniversary of the grant date or the next annual stockholder meeting. The vested shares will be delivered upon the earlier of the third anniversary of the grant, a change in control, or the end of Bardwell's service.
Varex Imaging Stockholders Reelect Directors, Back Pay Plan and Deloitte at 2026 Virtual AGM
Varex Imaging (NASDAQ: VREX) held its 2026 Annual Meeting of Stockholders virtually, where shareholders reelected all seven director nominees, approved the advisory vote on named executive officer compensation, and ratified Deloitte & Touche LLP as the company’s independent auditor for fiscal 2026. Approximately 92% of outstanding common stock was represented, establishing a quorum for the meeting led by independent board chair Walter Rosebrough. The final vote tallies will be filed with the SEC within four business days.
Varex Imaging (NASDAQ: VREX) details 2026 annual meeting vote results
Varex Imaging Corporation (NASDAQ: VREX) announced the results of its 2026 annual stockholders' meeting, where shareholders approved all proposals. These included the election of seven board directors, advisory approval of executive compensation, and the ratification of Deloitte & Touche LLP as the independent public accounting firm for fiscal year 2026. A strong quorum of approximately 92% of outstanding shares was represented at the meeting.
Varex Imaging (NASDAQ:VREX) Stock Rating Lowered by Wall Street Zen
Wall Street Zen downgraded Varex Imaging (NASDAQ:VREX) from a "strong-buy" to a "buy" rating, despite the company beating its recent quarterly earnings estimates with $0.19 EPS against an expected $0.14. The consensus rating from other analysts remains a "Hold" with a target price of $16.17. Varex Imaging reported revenue of $209.6 million and provided Q2 2026 guidance, but still faces a negative net margin and P/E ratio.
Varex Imaging (VREX) Returns To Quarterly Profit Challenging Persistent Loss Narrative
Varex Imaging (VREX) reported a return to quarterly profit in fiscal Q1 2026 with net income of US$2.3 million and revenue of US$209.6 million, challenging its persistent loss narrative. Despite a five-year trend of growing losses and modest revenue growth, bulls point to a low P/S ratio and a valuation below DCF fair value as potential upside. Bears, however, highlight thin interest coverage and volatility in net income, suggesting the profit may be a temporary blip.
Varex Imaging Corporation (NASDAQ:VREX) Q1 2026 Earnings Call Transcript
Varex Imaging Corporation (NASDAQ: VREX) reported a strong start to fiscal year 2026, with Q1 revenue of $210 million, up 5% year-over-year, driven by a 17% increase in their Industrial segment. The company's Medical segment remained stable, with increased customer engagement on new platforms and an optimistic outlook for future demand, particularly in CT and general radiography. Varex is also seeing significant traction in its Industrial segment, especially in cargo security systems and photon counting detectors for industrial applications, and is making strategic investments in manufacturing facilities in India to support global growth and market competitiveness.
Varex Imaging Corporation 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:VREX) 2026-02-11
Varex Imaging Corporation (NASDAQ:VREX) reported its Q1 2026 earnings, with an EPS of $0.19, beating estimates by $0.06, and revenue of $209.60 million, exceeding expectations by $1.80 million, representing a 4.90% year-over-year increase. The company released a slide deck for its earnings call on February 11, 2026. This content was prepared by Seeking Alpha's transcripts team.
Varex Imaging Earnings Report: Q1 Overview
Varex Imaging (NASDAQ: VREX) released its Q1 earnings, reporting an EPS of $0.19 against an estimate of $0.13, beating expectations by 46.15%. Revenue saw a $9.80 million increase year-over-year. The company also provided Q2 2026 guidance, expecting earnings between $0.15 and $0.25 per share.
Earnings call transcript: Varex Imaging beats Q1 2026 EPS forecast
Varex Imaging (VREX) reported strong Q1 FY2026 results, surpassing analyst expectations with an EPS of $0.19 against a forecast of $0.14, and revenue of $210 million, exceeding the $205.48 million forecast. The company saw a 5% year-over-year revenue increase, driven by growth in both medical and industrial segments, and its stock gained 1.85% in aftermarket trading. Varex highlighted positive customer engagement, particularly in new product development and photon counting technologies, and is focused on expanding manufacturing capabilities in India.
Varex Imaging Corp (NASDAQ:VREX) Beats Profit Estimates as Industrial Segment Drives Growth
Varex Imaging Corp (NASDAQ:VREX) exceeded profit expectations in its first fiscal quarter of 2026, driven by strong growth in its Industrial segment, despite revenue slightly missing estimates. Non-GAAP EPS reached $0.19, surpassing analyst predictions of $0.14, while revenue totaled $209.6 million. The company's shares reacted cautiously positive, trading higher in after-market activity, as the Industrial segment's 17% year-over-year growth offset the flat Medical segment performance.
Varex Announces Financial Results for First Quarter Fiscal Year 2026
Varex Imaging Corporation reported solid Q1 FY2026 financial results with revenues of $210 million, a 5% increase year-over-year, driven by strength in its cargo systems business. Non-GAAP diluted EPS increased to $0.19. The company provided Q2 FY2026 guidance, expecting revenues between $210 million and $225 million and non-GAAP EPS between $0.15 and $0.25.
Y Intercept Hong Kong Ltd Sells 318,294 Shares of Varex Imaging $VREX
Y Intercept Hong Kong Ltd significantly reduced its stake in Varex Imaging (NASDAQ:VREX) by selling 318,294 shares, cutting its position by 92.6% to 25,303 shares. Despite this large sale, other institutional investors like Pzena Investment Management and Qube Research & Technologies increased their holdings in Varex. The company recently surpassed earnings and revenue estimates, but analyst sentiment remains mixed with an average "Hold" rating.
Varex Imaging (VREX) director settles 10,339 deferred stock units into shares
Varex Imaging Corp director Walter M. Rosebrough Jr. converted 10,339 Deferred Stock Units into Varex common shares on February 9, 2026. These units, granted on February 9, 2023, vested on February 8, 2024, and were delivered on the third anniversary of the grant date. Following this transaction, Rosebrough directly owns 52,654 shares of common stock, with no cash consideration involved.
Can Varex Imaging Sustain Its Recent Rally?
Varex Imaging Corporation (US92214X1063) is set to release its Q1 2026 financial results on February 10, with investors closely watching to see if the company can maintain its recent stock rally. The company delivered strong Q4 2025 results, beating EPS and revenue estimates, but analysts are more conservative for Q1 2026, anticipating $0.14 EPS on $208 million revenue. The report and subsequent annual shareholder meeting will be crucial for the stock's future trajectory.
